4 October 2021 - The Australian Government has increased supplies of the promising COVID-19 treatment sotrovimab with over 15,000 additional doses arriving in Australia over recent days.
Sotrovimab is a novel monoclonal antibody and was approved for use by the TGA on 20 August 2021.